Skip to main content

Table 2 Increased transcript specificity by using the newly defined probe sets

From: Transcript-based redefinition of grouped oligonucleotide probe sets using AceView: High-resolution annotation for microarrays

  Affymetrix Probe Sets    Redefined Probe Sets  
Identifier Fold Gene symbol No. of variants Identifier Fold No. of variants Transcripts
38010_at 2.2 BNIP3 3 b0805_15050 2.24 2 BNIP3: a, b
31852_at 2.06 ANKMY2 3 b0805_979 2.01 2 ANKMY2: a, b
36813_at -3.15 TRIP13 3 b0805_19653 -3.94 2 TRIP13: a, e
38821_at 1.89 PGRMC2 3 b0805_3475 1.75 2 PGRMC2: a, d
33631_at -1.78 TXNL4A 5 b0805_2958 -2.71 2 TXNL4A: d, e
40916_at 1.97 BEXL1 3 b0805_642 2.35 2 BEXL1: a, c
39109_at -2.49 TPX2 4 b0805_8744 -2.44 2 TPX2: a, b
37985_at -1.78 LMNB1 3 b0805_7685 -1.75 2 LMNB1: a, c
34363_at 2.33 SEPP1 3 b0805_18077 6.87 2 SEPP1: c, f
37582_at 2.06 KRT15 4 b0805_20129 2.04 2 KRT15: a, c
34805_at -2.09 MGC2574 3 b0805_16254 -1.9 2 MGC2574: a, c
40117_at -2.26 MCM6 2 b0805_21229 -2.38 1 MCM6: a
37005_at 2.35 NBL1 3 b0805_14295 2.34 2 NBL1: a, b
40710_at 1.78 CLGN 2 b0805_21744 1.9 1 CLGN: b
36591_at -1.71 TUBA1 7 b0805_9382 -1.98 1 TUBA1: a
41583_at -2.98 FEN1 3 b0805_6644 -2.79 2 FEN1: a, c
35367_at 1.73 LGALS3 8 b0805_18811 1.78 2 LGALS3: a, c
41274_at 1.7 DKFZp667G2110 2 b0805_4597 1.74 1 DKFZp667G2110: a
39329_at -1.95 ACTN1 4 b0805_9591 -2.03 2 ACTN1: a, c
39809_at 2.19 HBP1 3 b0805_22136 2.17 2 HBP1: a, b
33891_at 2.77 CLIC4 2 b0805_15863 2.76 1 CLIC4: b
39441_at 2.92 LANCL1 2 b0805_1092 3 1 LANCL1: a
1884_s_at -2.12 PCNA 5 b0805_5909 -2.04 2 PCNA: a, b
41747_s_at 2.67 MEF2A 2 b0805_21100 3.22 1 MEF2A: e
35767_at 1.82 GABARAPL2 3 b0805_5736 2.01 2 GABARAPL2: a, c
41415_at -1.85 BYSL 3 b0805_3838 -2.07 2 BYSL: a, b
40414_at -2.44 VARS 4 b0805_873 -2.34 2 VARS: a, g
38728_at -2.06 NUP205 4 b0805_14227 -2.36 1 NUP205: a
39385_at -2.6 ANPEP 3 b0805_3943 -2.59 1 ANPEP: a
  1. The probe set identifiers ending with "_at" are from Affymetrix; and those beginning with "b0805_" are newly defined here. Fold changes are ratios of the mean values of the treatment versus values of the control group, and the negative values indicate changes in the opposite direction.